Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1936
DOI: 10.1042/bj0300291
|View full text |Cite
|
Sign up to set email alerts
|

Comparative activities of compounds of the androsterone-testosterone series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
7
0
1

Year Published

1936
1936
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(10 citation statements)
references
References 5 publications
(1 reference statement)
2
7
0
1
Order By: Relevance
“…The geometry of the steroid molecule at certain centers of asymmetry is known to be a critical factor in hormonal activity (3,21). This fact is substantiated by the present experimental results.…”
Section: Discussionsupporting
confidence: 80%
“…The geometry of the steroid molecule at certain centers of asymmetry is known to be a critical factor in hormonal activity (3,21). This fact is substantiated by the present experimental results.…”
Section: Discussionsupporting
confidence: 80%
“…Assays to detect androgenic properties have been developed since the 1930s (Korenchevsky, 1932;Korenchevsky et al, 1932Korenchevsky et al, , 1933aBülbring and Burn, 1935;Dingemanse et al, 1935;Deanesly and Parkes, 1936;Wainman and Shipounoff, 1941;Eisenberg et al, 1949;Eisenberg and Gordan, 1950;Di Salle et al, 1994), and the capabilities of the assays were demonstrated in 1953 by Hershberger et al when they analyzed the response of the ventral prostate, seminal vesicles and coagulating glands, and the levator ani without the bulbocavernosus muscle to a number of active chemicals, including estrogens and progesterones (Hershberger et al, 1953).…”
Section: Introductionmentioning
confidence: 98%
“…Uzun süreli etkin madde verilişinin, implante edilen ilaç salım sistemi şeklindeki uygulaması beşeri kullanım amacıyla düşünülmüş ve ilk kez 1861 yılında Lafarge`ın subkütan olarak implante edilen etkin madde pelletlerini geliştirmesi ile başlamıştır (1) (6,7,8). 1990`larda ise biyoparçalanabilir mikropartiküler şekiller geliştirilmiştir (9).…”
Section: Introductionunclassified